market-access advancing-medicine-requires-more-secure-supply-chains 
pharmaphorum
NOVEMBER 4, 2022
To address the supply chain vulnerabilities of the pharma industry, an innovative, collaborative blockchain-based system could help to keep track of drugs in transit and ensure they are stored in the correct conditions. The pace of technological advancement and focus in this area suggests that such a solution could be coming soon.
Roots Analysis
MARCH 1, 2024
In order to effectively combat the problems related to counterfeit medicines, several companies have come up with innovative technologies to provide the necessary tools to manufacturers, healthcare professionals and patients to authenticate pharmaceutical products. Such technologies have been shown to have highly secured features.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 24, 2023
The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. We are not the most attractive location at the moment.”
Pharmaceutical Technology
JUNE 19, 2023
Although only a small number of gene therapies have reached the market thus far, the industry is poised to grow quickly over the next few years. As the clinical trials industry adapts to the rising demand, it must also tackle important challenges concerning the way advanced medicines like cell and gene therapies are handled.
Viseven
OCTOBER 26, 2022
Supply Chain Disruptions. It’s hard for us to imagine that a hospital might tell a patient that their treatment needs to be delayed because of a medicine shortage or they are simply unavailable because of logistics challenges in pharmaceutical industry. Invest in software. Need for Qualified Professionals.
pharmaphorum
SEPTEMBER 29, 2020
Within the last two decades, large pharmaceutical corporations have established themselves firmly in oncology by prioritising internal R&D efforts, as well as developing and accessing novel science and technology through collaborations and alliances with biotech companies and academic institutions. A diversity of collaboration types.
European Pharmaceutical Review
JULY 25, 2022
While the global trade of fake pharmaceuticals has long been a threat, the COVID-19 pandemic sent the fraudulent market into overdrive. Criminals were able to capitalise on supply chain disruptions, industry regulations being in transition and the urgent global demand for medical products; consequently they thrived.
Expert insights. Personalized for you.
111 
Let's personalize your content